BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30199315)

  • 1. Intranasal Filtration of Inhaled Aerosol in Human Subjects as a Function of Nasal Pressure Drop.
    Golshahi L; Hosseini S
    J Aerosol Med Pulm Drug Deliv; 2019 Feb; 32(1):13-23. PubMed ID: 30199315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal deposition in infants and children.
    Zhou Y; Guo M; Xi J; Irshad H; Cheng YS
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):110-6. PubMed ID: 23586501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation.
    Carrigy NB; Ruzycki CA; Golshahi L; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):149-69. PubMed ID: 24870701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth of nasal and laryngeal airways in children: implications in breathing and inhaled aerosol dynamics.
    Xi J; Si X; Zhou Y; Kim J; Berlinski A
    Respir Care; 2014 Feb; 59(2):263-73. PubMed ID: 23821760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations to Estimate the Key Anatomical Dimensions of Pediatric Nasal Airways using Minimally Invasive Measurements of Intranasal Pressure Gradient.
    Hosseini S; Schuman TA; Golshahi L
    J Aerosol Med Pulm Drug Deliv; 2021 Jun; 34(3):171-180. PubMed ID: 32833574
    [No Abstract]   [Full Text] [Related]  

  • 6. Computational Models of Inhalation Therapy in Early Childhood: Therapeutic Aerosols in the Developing Acinus.
    Katan JT; Hofemeier P; Sznitman J
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):288-98. PubMed ID: 26907858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of electrostatic charge on deposition of uniformly charged monodisperse particles in the nasal extrathoracic airways of an infant.
    Azhdarzadeh M; Olfert JS; Vehring R; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):30-4. PubMed ID: 24689985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interindividual variability in nasal filtration as a function of nasal cavity geometry.
    Garcia GJ; Tewksbury EW; Wong BA; Kimbell JS
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):139-55. PubMed ID: 19422314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hood nebulization: effects of head direction and breathing mode on particle inhalability and deposition in a 7-month-old infant model.
    Kim J; Xi J; Si X; Berlinski A; Su WC
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):209-18. PubMed ID: 23808762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol deposition in the nose as a function of body size.
    Phalen RF; Oldham MJ; Mautz WJ
    Health Phys; 1989; 57 Suppl 1():299-305. PubMed ID: 2606689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Steps to Develop and Validate a CFPD Model in Order to Support the Design of Nose-to-Brain Delivered Biopharmaceuticals.
    Engelhardt L; Röhm M; Mavoungou C; Schindowski K; Schafmeister A; Simon U
    Pharm Res; 2016 Jun; 33(6):1337-50. PubMed ID: 26887679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breathing resistance and ultrafine particle deposition in nasal-laryngeal airways of a newborn, an infant, a child, and an adult.
    Xi J; Berlinski A; Zhou Y; Greenberg B; Ou X
    Ann Biomed Eng; 2012 Dec; 40(12):2579-95. PubMed ID: 22660850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Computational Study of Nasal Spray Deposition Pattern in Four Ethnic Groups.
    Keeler JA; Patki A; Woodard CR; Frank-Ito DO
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):153-66. PubMed ID: 26270330
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Hosseini S; Wei X; Wilkins JV; Fergusson CP; Mohammadi R; Vorona G; Golshahi L
    J Aerosol Med Pulm Drug Deliv; 2019 Dec; 32(6):374-385. PubMed ID: 31464547
    [No Abstract]   [Full Text] [Related]  

  • 15. Intranasal Deposition of Accuspray™ Aerosol in Anatomically Correct Models of 2-, 5-, and 12-Year-Old Children.
    Laube BL; Sharpless G; Vikani AR; Harrand V; Zinreich SJ; Sedberry K; Knaus D; Barry J; Papania M
    J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):320-33. PubMed ID: 25679810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.
    Byron PR; Hindle M; Lange CF; Longest PW; McRobbie D; Oldham MJ; Olsson B; Thiel CG; Wachtel H; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S59-69. PubMed ID: 21133801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of Particles in the Alveolar Airways: Inhalation and Breath-Hold with Pharmaceutical Aerosols.
    Khajeh-Hosseini-Dalasm N; Longest PW
    J Aerosol Sci; 2015 Jan; 79():15-30. PubMed ID: 25382867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling age-related particle deposition in humans.
    Asgharian B; Ménache MG; Miller FJ
    J Aerosol Med; 2004; 17(3):213-24. PubMed ID: 15625813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro evaluation of importance of airway anatomy in sub-regional nasal and paranasal drug delivery with nebulizers using three different anatomical nasal airway replicas of 2-, 5- and 50-Year old human subjects.
    Hosseini S; Golshahi L
    Int J Pharm; 2019 May; 563():426-436. PubMed ID: 30974192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the lung delivery of nasally administered aerosols during noninvasive ventilation-an application of enhanced condensational growth (ECG).
    Longest PW; Tian G; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2011 Apr; 24(2):103-18. PubMed ID: 21410327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.